Tag: Participants
-
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
Condition: AsthmaInterventions: Drug: MSTT1041A; Drug: PlaceboSponsor: Hoffmann-La RocheRecruiting – verified September 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
Condition: AsthmaIntervention: Drug: VR588Sponsors: Imperial College London; Vectura LimitedRecruiting – verified February 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
Condition: AsthmaInterventions: Drug: MK-1029 150 mg; Drug: Placebo for MK-1029; Drug: Montelukast 10 mg; Drug: Albuterol/Salbutamol 90 mcg – 100 mcg per inhalationSponsor: Merck Sharp & Dohme Corp.Not yet recruiting – verified March 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Condition: AsthmaInterventions: Drug: Lebrikizumab; Device: Prefilled SyringesSponsor: Hoffmann-La RocheNot yet recruiting – verified September 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
Condition: AsthmaIntervention: Other: Laboratory biomarker analysisSponsor: Hoffmann-La RocheRecruiting – verified September 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Percentage of participants have asthma exacerbations up to 2 years after … – Healio
Percentage of participants have asthma exacerbations up to 2 years after …Healio“The current study suggests that the asthma exacerbation risk after stepping down asthma medication is similar to previous reports despite differences in patient selection, study setting and length of follow-up,” Matthew A. Rank, MD, of the Division of … View full post on asthma…
-
A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants
Conditions: Dermatitis, Atopic; Asthma; HealthyIntervention: Other: Allergic Skin Reaction (ASR) Testing and Skin Blister InductionSponsor: Janssen Research & Development, LLCNot yet recruiting – verified January 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condition: AsthmaInterventions: Biological: Mepolizumab; Drug: Placebo; Drug: SOCSponsor: GlaxoSmithKlineNot yet recruiting – verified October 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
Conditions: Healthy; AsthmaInterventions: Drug: JNJ-43260295; Drug: Placebo; Other: Nasal Allergen ChallengeSponsor: Janssen Research & Development, LLCNot yet recruiting – verified September 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma
Condition: AsthmaInterventions: Drug: Beclomethasone dipropionate; Drug: Placebo; Drug: albuterol/salbutamol 90 mcgSponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.Recruiting – verified January 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days